Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Alzheimer Disease
Clinical trial register · Spain

Alzheimer Disease Trials in Spain, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5882 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:19 UTC
5882
Studies in scope
all four open statuses
3093
Recruiting now
open to new participants
1126
Lead sponsors
across recruiting studies
Top sites
Barcelona 16 Madrid 8 Pamplona 5 Seville 5 Salamanca 4

Alzheimer Disease trials in Spain

22 of 5882 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Not yet open
AB Science
Phase 3
600
Albacete, Barcelona, Donostia / San Sebastian, Granada, Madrid, Murcia, Pamplona, Zamora
2026-06
Not yet open
DIV-AD BARCELONA: Alzheimer's Blood-Based Biomakers for a Diverse Community
NCT07521722Alzheimer Disease, Cognitive Dysfunction, Cognitive Disorder, Dementia, Neurodegenerative Disease
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
Observational
250
Barcelona
2026-04-27
By invitation
Retrospective Observational Study of Blood-based Biomarkers in the Diagnosis and Monitoring of Patients With a Neurodegenerative Disease or Mental Disorder
NCT07314190Alzheimer Disease, Dementia With Lewy Bodies (DLB), Frontotemporal Dementia (FTD), Major Depressive Disorder (MDD)
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Observational
1,799
Barcelona
2026-02-19
By invitation
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Observational
1,310
Barcelona
2026-02-01
Recruiting
Bristol-Myers Squibb
Phase 3
650
Getxo, Elche (alicante), Madrid, Málaga, Pamplona, Salamanca, Seville, Terrassa
2025-12-02
Recruiting
Bristol-Myers Squibb
Phase 3
426
Getxo, Elche (alicante), Madrid, Málaga, Pamplona, Salamanca, Seville, Terrassa
2025-07-10
Not yet open
The COMFORTage Project at Ace Alzheimer Center Barcelona
NCT07031167Alzheimer Disease, Mild Cognitive Impairment
Fundació ACE Institut Català de Neurociències Aplicades
Not applicable
100
Barcelona
2025-07-01
By invitation
Braingaze
Not applicable
60
Mataró
2025-05-01
Recruiting
The Link Between Physical Activity and Brain Health in Healthy Adults
NCT07025070Alzheimer Disease, Inactivity, Preventive Therapy
Technical University of Madrid
Observational
60
Madrid
2024-11-25
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
406
Majadahonda, Málaga, Lleida, Madrid, Salamanca, Seville, Valladolid, Zaragoza
2024-09-26
Recruiting
Intra-Cellular Therapies, Inc.
Phase 2
370
Albacete, Zamora, Zaragoza
2024-08-15
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 2
55
Barcelona, Getxo, Lleida, Madrid, Pamplona, Pozuelo de Alarcón, Sant Cugat del Vallès, Terrassa
2024-07-22
Active, closed
Acumen Pharmaceuticals
Phase 2
542
Sant Cugat del Vallès, Cuarte de Huerva, Barcelona, Donostia / San Sebastian, Getxo, Madrid, Seville, Valencia
2024-02-29
Recruiting
Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia
NCT05741853Primary Progressive Aphasia, Dementia, Dementia, Frontotemporal, Alzheimer Disease
Stephanie Grasso
Not applicable
60
Barcelona
2023-05-01
Active, closed
Novartis Pharmaceuticals
Phase 1
38
Valencia, Barcelona
2023-02-23
Active, closed
AriBio Co., Ltd.
Phase 3
1,535
Barcelona, Huelva, Madrid, Pamplona, Salamanca, San Sebastián, Seville, Valencia
2022-12-23
Active, closed
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
NCT05508789Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases
Eli Lilly and Company
Phase 3
1,500
Barcelona, Lleida, Sant Cugat del Vallès, Valencia
2022-10-10
Active, closed
Tharick Pascoal
Phase 1
822
Barcelona
2022-03-02
Recruiting
Trial-Ready Cohort-Down Syndrome (TRC-DS)
NCT04165109Down Syndrome, Alzheimer Disease, Dementia
University of Southern California
Observational
550
Barcelona
2021-06-07
Active, closed
β-AARC: Cohort Study for the Identification of Blood-based Biomarkers in a Population With Subjective Cognitive Decline
NCT04935372Alzheimer Disease, Preclinical Alzheimer, Mild Cognitive Impairment
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
Observational
200
Barcelona
2021-05-25
Active, closed
Longitudinal Early-onset Alzheimer's Disease Study Protocol
NCT03507257Early Onset Alzheimer Disease, Alzheimer Disease, Mild Cognitive Impairment
Indiana University
Observational
850
Barcelona
2018-04-30
Recruiting
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
Observational
400
Barcelona
2018-02-12
Rows per page Showing 1–22 of 22
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-spain/condition/alzheimer-disease

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,882 studies in total at the last sync on 10 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 22 of those studies listing the condition Alzheimer Disease.

How many Alzheimer Disease trials are recruiting in Spain?

8 of the 22 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:19 UTC sync. A further 3 have not yet opened recruitment, 8 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Alzheimer Disease), 22 studies
PhaseStudiesRecruitingShare
Observational8336.4%
Phase 36327.3%
Not applicable3113.6%
Phase 23113.6%
Phase 1209.1%

Most active sponsors

Lead sponsors with the most studies (Alzheimer Disease)
Lead sponsorStudiesRecruiting
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation31
Bristol-Myers Squibb22
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau20
AB Science10
Acumen Pharmaceuticals10
AriBio Co., Ltd.10
Braingaze10
Eli Lilly and Company10
Fundació ACE Institut Català de Neurociències Aplicades10
Indiana University10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.